Cost-effectiveness of antiviral therapy during late pregnancy to prevent perinatal transmission of hepatitis B virus

Cost-effectiveness of antiviral therapy during late pregnancy to prevent perinatal transmission of hepatitis B virus

Background. Hepatitis B virus (HBV) infections are perinatally transmitted from chronically infected mothers. Supplemental antiviral therapy during late pregnancy with lamivudine (LAM), telbivudine (LdT), or tenofovir (TDF) can substantially reduce perinatal HBV transmission compared to postnatal im...

Full description

Bibliographic Details
Main Authors: Wenjun Wang, Jingjing Wang, Shuangsuo Dang, Guihua Zhuang
Format: Article
Language:English
Published: PeerJ Inc. 2016-03-01
Series:PeerJ
Subjects:
Cost-effective
Pregnancy
Lamivudine
Telbivudine
Tenofovir
Hepatitis b virus
Online Access:https://peerj.com/articles/1709.pdf

Internet

https://peerj.com/articles/1709.pdf

Similar Items